Ontology of Drug Adverse Events

Last uploaded: January 12, 2019
Jump to:
loading...
Preferred Name

Carmustine [Chemical/Ingredient]
Synonyms
ID

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006684
code

C23716
Display_Name

Carmustine
imported from

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl
label

Carmustine [Chemical/Ingredient]
MeSH_CUI

M0003490
MeSH_Definition

A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
MeSH_DUI

D002330
MeSH_Name

Carmustine
NUI

N0000006684
prefixIRI

NDF-RT:N0000006684
prefLabel

Carmustine [Chemical/Ingredient]
RxNorm_CUI

2105
RxNorm_Name

Carmustine
Synonym

1,3-Bis(2-Chloroethyl)-1-Nitrosourea

Urea, N,N'-bis(2-chloroethyl)-N-nitroso-

N,N'-Bis(2-Chloroethyl)-N-Nitrosourea

BCNU

FIVB
UMLS_CUI

C0007257
subClassOf

http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007812
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display